BeStock  
Stocks › Biotechnology › QURE

uniQure NV QURE

US equityMarket cap rank #2941Biotechnology
$22.80 −$0.66 (-2.81%)
Pre-market · Oct 6, 4:20 am ET · After hours $22.57 -1.03%
Open$22.28
Prev close$23.46
Day range$21.37 – $23.24
Volume3.04M
Market cap$1.58B
P/E (TTM)–
Dividend yield–

QURE Stock News

Headlines matching uniQure NV or the QURE ticker, most recent first.

  • A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $31 to $80Market news · 30 Sep 2026
  • Analysts' Top Healthcare Picks: UniQure (QURE), Alumis Inc. (ALMS)TipRanks · 3 Sep 2026
  • Wells Fargo Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $75Market news · 3 Sep 2026
  • TD Cowen Maintains UniQure NV(QURE.US) With Buy RatingMarket news · 3 Sep 2026
  • Stifel Maintains UniQure NV(QURE.US) With Buy RatingMarket news · 29 Sep 2026
  • William Blair Upgrades UniQure NV(QURE.US) to Buy RatingMarket news · 2 Sep 2026
  • Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $71Market news · 14 Aug 2026
  • H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $80Market news · 31 Jul 2026
  • Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Fortrea Holdings Inc. (FTRE) and UniQure (QURE)TipRanks · 30 Jul 2026
  • A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $46 to $68Market news · 30 Jul 2026
  • Goldman Sachs Maintains UniQure NV(QURE.US) With Hold Rating, Maintains Target Price $46Market news · 30 Jul 2026
  • H.C. Wainwright Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $80Market news · 29 Jun 2026
  • Mizuho Securities Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $68Market news · 25 Jun 2026
  • Barclays Maintains UniQure NV(QURE.US) With Buy Rating, Maintains Target Price $65Market news · 23 Jun 2026
  • Stifel Maintains UniQure NV(QURE.US) With Buy Rating, Raises Target Price to $71Market news · 22 Jun 2026

Discussion

No comments yet — be the first to weigh in on QURE.

Leave a comment

Scroll to Top